ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

URGN UroGen Pharma Ltd

14.17
-0.04 (-0.28%)
Last Updated: 11:04:15
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
UroGen Pharma Ltd URGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -0.28% 14.17 11:04:15
Open Price Low Price High Price Close Price Prev Close
14.05 13.77 14.235 14.21
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/17/202412:02BWUroGen Announces New Data Presentations at the American..
4/15/202408:00BWUroGen Announces FDA Acceptance of Investigational New Drug..
4/03/202408:00BWUroGen Pharma Files Patent Infringement Action Against Teva..
3/14/202408:00BWUroGen Pharma Delivers Double Digit JELMYTO® Growth and..
3/08/202408:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
3/04/202408:00BWUroGen Pharma to Report Fourth Quarter and Full-Year 2023..
3/04/202407:00EDGAR2Form 8-K - Current report
3/01/202407:00EDGAR2Form 8-K - Current report
2/26/202408:00BWUroGen Pharma to Present at TD Cowen 44th Annual Health Care..
2/12/202417:47EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2/07/202416:15EDGAR2Form 8-K - Current report
2/02/202419:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202410:13EDGAR2Form 144 - Report of proposed sale of securities
2/01/202409:53EDGAR2Form 144 - Report of proposed sale of securities
2/01/202408:00BWUroGen Pharma to Participate at Upcoming Investor..
1/24/202408:00BWUroGen Initiates Submission of a Rolling NDA to the FDA for..
1/17/202416:16EDGAR2Form 8-K - Current report
1/17/202408:00BWUroGen Secures Exclusive License from medac GmbH to Develop..
1/11/202408:00BWUroGen Pharma to Participate in the B. Riley Healthcare..
1/02/202408:04EDGAR2Form 8-K - Current report
12/08/202316:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
11/14/202316:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/14/202308:00BWUroGen Pharma Reports Third Quarter 2023 Financial Results
11/13/202308:00BWUroGen will Present Scientific Advances in Bladder Cancer at..
11/07/202308:00BWUroGen Pharma to Report Third Quarter 2023 Financial Results..
10/03/202308:00BWFollowing Pre-NDA Meeting with the FDA, UroGen Announces..
9/11/202316:15EDGAR2Form 8-K - Current report
9/11/202307:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
9/08/202316:16EDGAR2Form S-3 - Registration statement under Securities Act of..
9/08/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202308:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
9/05/202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/31/202308:00BWUroGen Pharma to Present at Upcoming Investor Conferences
8/10/202308:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202308:01EDGAR2Form 8-K - Current report
8/10/202308:00BWUroGen Pharma Reports Record JELMYTO Quarterly Sales and..
8/08/202308:00BWThe Journal of Urology Publishes Peer-Reviewed Article..
8/04/202308:56EDGAR2Form SC 13D - General statement of acquisition of beneficial..
8/02/202317:00BWUroGen Pharma to Report Second Quarter 2023 Financial..
8/01/202316:23EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
8/01/202316:21EDGAR2Form DEF 14A - Other definitive proxy statements

Your Recent History

Delayed Upgrade Clock